(0)サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1485800

神経バイオマーカー用免疫測定市場：疾患タイプ別、製品タイプ別、エンドユーザー別、技術別、国別、地域別：産業分析、市場規模、市場シェア、2024年～2032年予測

Immunoassay for Neurological Biomarkers Market, By Disease Type, By Product, By End User, By Technology, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日
ページ情報
英文 397 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=145.06円
神経バイオマーカー用免疫測定市場：疾患タイプ別、製品タイプ別、エンドユーザー別、技術別、国別、地域別：産業分析、市場規模、市場シェア、2024年～2032年予測
出版日: 2024年05月13日
発行: AnalystView Market Insights
ページ情報: 英文 397 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

レポートハイライト

神経学的バイオマーカー用免疫測定法市場規模は2023年に7億767万米ドルとなり、2024～2032年にかけてCAGR 17.5%で拡大

神経バイオマーカー用免疫測定法市場-市場力学

神経疾患と精神疾患の増加

神経バイオマーカー用免疫測定市場は、神経疾患と精神疾患の検出と診断において重要な役割を果たしています。免疫測定は、アルツハイマー病、パーキンソン病、多発性硬化症など、さまざまな疾患に関連する神経バイオマーカーの早期検出を可能にします。早期発見により、早期介入・早期治療が可能となり、疾患の進行を遅らせ、患者の予後を改善できる可能性があります。世界保健機関（WHO）によると、世界中で30億人以上が病気や障害のために神経症状とともに生活しています。さらに、神経疾患による死亡の80％以上は低・中所得国で発生しています。

神経バイオマーカー用免疫測定市場-主要洞察

弊社のリサーチアナリストの分析によると、世界市場は予測期間（2024～2032年）に約17.5%のCAGRで毎年成長すると予測されています。

市場セグメンテーションでは、アルツハイマー病が2023年に最大の市場シェアを示すと予測されています。

技術セグメンテーション別では、2023年には放射免疫測定法（RIA）が主要タイプでした。

エンドユーザーセグメンテーション別では、2023年には病院が主要タイプでした。

地域別では、北米が2023年の主要収益源であった

神経バイオマーカー用免疫測定市場-セグメンテーション分析：

神経バイオマーカー用免疫測定の世界市場は、疾患タイプ、製品タイプ、エンドユーザー、技術、地域に基づいてセグメント化されます。

市場は疾患タイプに基づいて6つのカテゴリーに分けられます：バイオマーカー用免疫測定は、臨床症状が現れる前からADの早期発見を可能にします。免疫測定は、ADの新しい治療法の開発を目的とした臨床試験で広く使用されています。研究者は、バイオマーカーのレベルに対する実験的治療の影響を測定し、その潜在的な有効性と安全性を評価することができます。

市場はエンドユーザーによって6つのカテゴリーに分けられます：神経バイオマーカー用免疫測定は、神経疾患の診断、予後、モニタリングに関連する様々な目的で病院で広く使用されています。例えば、特定のバイオマーカーのレベルは、病気の重症度や進行度を示し、臨床医が病気の経過を予測し、適切な治療戦略を立案するのに役立ちます。

神経バイオマーカー用免疫測定市場-地理的洞察

地理的には、この市場は北米、ラテンアメリカ、欧州、アジア太平洋、中東・アフリカの各地域に広がっています。これらの地域は、ビジネスをもたらす国によってさらに分けられます。

北米は、免疫測定神経学バイオマーカー市場において、収益面で世界最大の市場シェアを占めています。これは、政府の取り組みが充実していることと、経済が好調であることによる。米国はこの市場をリードしており、その背景には分子診断の普及があります。欧州では、競争の激化と国民の意識の高まりにより市場が拡大しています。利害関係者がタンパク質、関連生体分子、遺伝子を含む研究プロジェクトに注力していることが、欧州の神経免疫測定市場の成長を促す主要要因となっています。

神経バイオマーカー用免疫測定市場-競合情勢：

神経バイオマーカー用免疫測定市場は、市場参入企業によるさまざまな戦略的取り組みによって急速に拡大しています。これらの取り組みには、診断と治療研究のための高度なバイオマーカー技術の開発が含まれます。例えば、2022年12月、米国FDAはF. Hoffmann-La Roche Ltd.が開発した2つの免疫測定を承認しました。これらの免疫測定は、Elecsys Phospho-Tau（181P）CSF（pTau181）とElecsysβ-Amyloid（1-42）CSF II（Abeta42）です。これらのアッセイは、成人患者における2つの重要なバイオマーカー、タウ蛋白とβアミロイドの測定に有用です。アルツハイマー病の診断確定に役立ちます。

目次

第1章 神経バイオマーカー用免疫測定市場概要

  • 調査範囲
  • 市場推定年

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 神経バイオマーカー用免疫測定法の主要市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 神経バイオマーカー用免疫測定業界研究

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長展望マッピング
  • 規制枠組み分析

第5章 神経バイオマーカー用免疫測定市場： COVID-19の影響分析

  • COVID-19前の影響分析
  • COVID-19後の影響分析

第6章 神経バイオマーカー用免疫測定市場情勢

  • 神経バイオマーカー用免疫測定市場シェア分析、2023年
  • 主要メーカー別内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 神経バイオマーカー用免疫測定市場-疾患タイプ別

  • 概要
    • 疾病タイプ別セグメントシェア分析
    • アルツハイマー病
    • パーキンソン病
    • ハンチントン病
    • 筋萎縮性側索硬化症（ALS）
    • 脊髄性筋萎縮症（SMA）
    • その他

第8章 神経バイオマーカー用免疫測定市場-製品別

  • 概要
    • 製品別セグメントシェア分析
    • 機器
    • 試薬
    • サービス

第9章 神経バイオマーカー用免疫測定市場-エンドユーザー別

  • 概要
    • エンドユーザー別セグメントシェア分析
    • 病院
    • クリニック
    • 学術団体
    • バイオ医薬品企業
    • 製薬会社
    • その他

第10章 神経バイオマーカー用免疫測定市場-技術別

  • 概要
    • 技術別セグメントシェア分析
    • 放射免疫測定法（RIA）
    • ポリメラーゼ連鎖反応（PCR）
    • ELISA
    • ウエスタンブロット
    • 迅速検査
    • ELISPOT

第11章 神経バイオマーカー用免疫測定市場-地域

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋
    • 概要
    • アジア太平洋の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東・アフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第12章 主要ベンダー分析-神経バイオマーカー用免疫測定業界

  • 競合ダッシュボード
  • 企業プロファイル
    • QIAGEN
    • Abbott
    • Merck &Co., Inc.
    • Johnson &Johnson Services, Inc.
    • Thermo Fisher Scientific, Inc.
    • Bio-Rad Laboratories, Inc.
    • Sysmex Corporation
    • Merck KGaA
    • F. Hoffmann La-Roche Ltd.
    • Nimble Therapeutics
    • ADx NeuroSciences NV
    • Enrolmmun
    • ACOBIOM
    • Banyan Biomarkers Inc.
    • Olink Biosciences
    • その他

第13章 アナリストの全方位展望

図表

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Immunoassay For Neurological Biomarkers Market: Disease Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Disease Type
  • TABLE Global Immunoassay For Neurological Biomarkers Market, by Disease Type 2019-2032 (USD Million)
  • TABLE Immunoassay For Neurological Biomarkers Market: Product Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Product
  • TABLE Global Immunoassay For Neurological Biomarkers Market, by Product 2019-2032 (USD Million)
  • TABLE Immunoassay For Neurological Biomarkers Market: End User Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by End User
  • TABLE Global Immunoassay For Neurological Biomarkers Market, by End User 2019-2032 (USD Million)
  • TABLE Immunoassay For Neurological Biomarkers Market: Technology Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Technology
  • TABLE Global Immunoassay For Neurological Biomarkers Market, by Technology 2019-2032 (USD Million)
  • TABLE Immunoassay For Neurological Biomarkers Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Immunoassay For Neurological Biomarkers Market, by Region 2019-2032 (USD Million)
  • TABLE North America Immunoassay For Neurological Biomarkers Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Immunoassay For Neurological Biomarkers Market, by Disease Type, 2019-2032 (USD Million)
  • TABLE North America Immunoassay For Neurological Biomarkers Market, by Product, 2019-2032 (USD Million)
  • TABLE North America Immunoassay For Neurological Biomarkers Market, by End User, 2019-2032 (USD Million)
  • TABLE North America Immunoassay For Neurological Biomarkers Market, by Technology, 2019-2032 (USD Million)
  • TABLE Europe Immunoassay For Neurological Biomarkers Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Immunoassay For Neurological Biomarkers Market, by Disease Type, 2019-2032 (USD Million)
  • TABLE Europe Immunoassay For Neurological Biomarkers Market, by Product, 2019-2032 (USD Million)
  • TABLE Europe Immunoassay For Neurological Biomarkers Market, by End User, 2019-2032 (USD Million)
  • TABLE Europe Immunoassay For Neurological Biomarkers Market, by Technology, 2019-2032 (USD Million)
  • TABLE Asia Pacific Immunoassay For Neurological Biomarkers Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Immunoassay For Neurological Biomarkers Market, by Disease Type, 2019-2032 (USD Million)
  • TABLE Asia Pacific Immunoassay For Neurological Biomarkers Market, by Product, 2019-2032 (USD Million)
  • TABLE Asia Pacific Immunoassay For Neurological Biomarkers Market, by End User, 2019-2032 (USD Million)
  • TABLE Asia Pacific Immunoassay For Neurological Biomarkers Market, by Technology, 2019-2032 (USD Million)
  • TABLE Latin America Immunoassay For Neurological Biomarkers Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Immunoassay For Neurological Biomarkers Market, by Disease Type, 2019-2032 (USD Million)
  • TABLE Latin America Immunoassay For Neurological Biomarkers Market, by Product, 2019-2032 (USD Million)
  • TABLE Latin America Immunoassay For Neurological Biomarkers Market, by End User, 2019-2032 (USD Million)
  • TABLE Latin America Immunoassay For Neurological Biomarkers Market, by Technology, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Immunoassay For Neurological Biomarkers Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Immunoassay For Neurological Biomarkers Market, by Disease Type, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Immunoassay For Neurological Biomarkers Market, by Product, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Immunoassay For Neurological Biomarkers Market, by End User, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Immunoassay For Neurological Biomarkers Market, by Technology, 2019-2032 (USD Million)
目次
Product Code: ANV2703

REPORT HIGHLIGHT

Immunoassay for Neurological Biomarkers Market size was valued at USD 707.67 Million in 2023, expanding at a CAGR of 17.5% from 2024 to 2032.

Immunoassays for neurological biomarkers are laboratory techniques used to measure the levels of certain molecules in biological samples, such as blood or cerebrospinal fluid, that are indicative of neurological conditions or diseases. The rising prevalence of neurological disorders like Alzheimer's disease, Parkinson's disease, and multiple sclerosis creates a growing need for reliable biomarkers for early diagnosis, prognosis, and monitoring of disease progression. However, the market is facing some regulatory approval for new biomarkers and immunoassays which can be a lengthy and costly process, hindering the translation of research findings into clinically useful diagnostics. Furthermore, there is a growing emphasis on the development of biomarkers for early diagnosis and monitoring of neurological diseases, creating opportunities in future.

Immunoassay for Neurological Biomarkers Market- Market Dynamics

Rising cases of neurological and psychiatric disorders

The Immunoassay for Neurological Biomarkers market plays a significant role in the detection and diagnosis of neurological and psychiatric disorders. Immunoassays allow for the early detection of neurological biomarkers associated with various disorders such as Alzheimer's disease, Parkinson's disease, multiple sclerosis, and others. Early detection enables early intervention and treatment, potentially slowing down disease progression and improving patient outcomes. According to the World Health Organization (WHO), more than 3 billion people worldwide are living with a neurological condition due to illness & disability. In addition, over 80% of neurological deaths occur in low- and middle-income countries.

Immunoassay for Neurological Biomarkers Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 17.5% over the forecast period (2024-2032)

Based on disease type segmentation, Alzheimer's disease was predicted to show maximum market share in the year 2023

Based on technology segmentation, radioimmunoassays (RIA) was the leading type in 2023

Based on end user segmentation, hospitals were the leading type in 2023

Based on region, North America was the leading revenue generator in 2023

Immunoassay for Neurological Biomarkers Market- Segmentation Analysis:

The Global Immunoassay for Neurological Biomarkers Market is segmented based on Disease Type, Product, End User, Technology, and Region.

The market is divided into six categories based on disease type: Biomarker immunoassays enable early detection of AD even before clinical symptoms appear. Immunoassays are widely used in clinical trials aimed at developing new therapies for AD. They help researchers measure the impact of experimental treatments on biomarker levels and assess their potential efficacy and safety.

The market is divided into six categories based on end user: Immunoassays for neurological biomarkers are widely used in hospitals for various purposes related to the diagnosis, prognosis, and monitoring of neurological disorders. For instance, levels of certain biomarkers might indicate the severity or progression of a disease, helping clinicians predict the likely course of the illness and plan appropriate treatment strategies.

Immunoassay for Neurological Biomarkers Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

North America has the largest market share in terms of revenue across the world for the immunoassay neurological biomarkers market. This is due to better government initiatives and a strong economy. The United States is a leader in this market, driven by the increasing use of molecular diagnosis. In Europe, the market is growing due to rising competition and increased awareness among the population. The stakeholders' focus on research projects involving proteins, associated biomolecules, and genes are the key factors driving the growth of the neuro immunoassay market in Europe.

Immunoassay for Neurological Biomarkers Market- Competitive Landscape:

The market for immunoassays used for neurological biomarkers is expanding rapidly due to various strategic initiatives taken by market players. These initiatives include the development of advanced biomarker technology for diagnostic and treatment research. For instance, in December 2022, the United States FDA approved two immunoassays developed by F. Hoffmann-La Roche Ltd. These immunoassays are Elecsys Phospho-Tau (181P) CSF (pTau181) and Elecsys beta-Amyloid (1-42) CSF II (Abeta42). These assays are useful for measuring two important biomarkers, tau proteins, and beta-amyloid, in adult patients. They aid in the confirmation of Alzheimer's disease diagnosis.

Recent Developments:

In February 2024, Abbott and Fujirebio announced partnering to develop a research-use-only test for the neurofilament-light chain (NfL). The neurology biomarker assay will be available for use on Abbott's Alinity I instrument and also will be offered to researchers conducting studies demonstrating the utility of the NfL biomarker.

In March 2023, H.U. Group Holdings Inc. and its subsidiary, Fujirebio, announced the release of two new assays, Lumipulse G NfL CSF and Lumipulse G NfL Blood, for LUMIPULSE G immunoassay systems. These CLEIA assays enable the accurate measurement of Neurofilament light (NfL) in human Cerebrospinal fluid (CSF) and plasma/serum, respectively.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL IMMUNOASSAY FOR NEUROLOGICAL BIOMARKERS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

QIAGEN

Abbott

Merck & Co., Inc.

Johnson & Johnson Services, Inc.

Thermo Fisher Scientific, Inc.

Bio-Rad Laboratories, Inc.

Sysmex Corporation

Merck KGaA

F. Hoffmann La-Roche Ltd.

Nimble Therapeutics

ADx NeuroSciences NV

Enrolmmun

ACOBIOM

Banyan Biomarkers Inc.

Olink Biosciences

Others

GLOBAL IMMUNOASSAY FOR NEUROLOGICAL BIOMARKERS MARKET, BY DISEASE TYPE- MARKET ANALYSIS, 2019 - 2032

  • Alzheimer's Disease
  • Parkinson's Disease
  • Huntington's Disease
  • Amyotrophic Lateral Sclerosis (ALS)
  • Spinal Muscular Atrophy (SMA)
  • Others

GLOBAL IMMUNOASSAY FOR NEUROLOGICAL BIOMARKERS MARKET, BY PRODUCT- MARKET ANALYSIS, 2019 - 2032

  • Instruments
  • Reagents
  • Services

GLOBAL IMMUNOASSAY FOR NEUROLOGICAL BIOMARKERS MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals
  • Clinics
  • Academic Organizations
  • Biopharmaceutical Companies
  • Pharmaceutical Companies
  • Others

GLOBAL IMMUNOASSAY FOR NEUROLOGICAL BIOMARKERS MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032

  • Radioimmunoassays (RIA)
  • Polymerase Chain Reaction (PCR)
  • ELISA
  • Western Blot
  • Rapid Tests
  • ELISPOT

GLOBAL IMMUNOASSAY FOR NEUROLOGICAL BIOMARKERS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1.Immunoassay For Neurological Biomarkers Market Overview

  • 1.1.Study Scope
  • 1.2.Market Estimation Years

2.Executive Summary

  • 2.1.Market Snippet
    • 2.1.1.Immunoassay For Neurological Biomarkers Market Snippet by Disease Type
    • 2.1.2.Immunoassay For Neurological Biomarkers Market Snippet by Product
    • 2.1.3.Immunoassay For Neurological Biomarkers Market Snippet by End User
    • 2.1.4.Immunoassay For Neurological Biomarkers Market Snippet by Technology
    • 2.1.5.Immunoassay For Neurological Biomarkers Market Snippet by Country
    • 2.1.6.Immunoassay For Neurological Biomarkers Market Snippet by Region
  • 2.2.Competitive Insights

3.Immunoassay For Neurological Biomarkers Key Market Trends

  • 3.1.Immunoassay For Neurological Biomarkers Market Drivers
    • 3.1.1.Impact Analysis of Market Drivers
  • 3.2.Immunoassay For Neurological Biomarkers Market Restraints
    • 3.2.1.Impact Analysis of Market Restraints
  • 3.3.Immunoassay For Neurological Biomarkers Market Opportunities
  • 3.4.Immunoassay For Neurological Biomarkers Market Future Trends

4.Immunoassay For Neurological Biomarkers Industry Study

  • 4.1.PEST Analysis
  • 4.2.Porter's Five Forces Analysis
  • 4.3.Growth Prospect Mapping
  • 4.4.Regulatory Framework Analysis

5.Immunoassay For Neurological Biomarkers Market: COVID-19 Impact Analysis

  • 5.1.Pre-COVID-19 Impact Analysis
  • 5.2.Post-COVID-19 Impact Analysis
    • 5.2.1.Top Performing Segments
    • 5.2.2.Marginal Growth Segments
    • 5.2.3.Top Looser Segments
    • 5.2.4.Marginal Loss Segments

6.Immunoassay For Neurological Biomarkers Market Landscape

  • 6.1.Immunoassay For Neurological Biomarkers Market Share Analysis, 2023
  • 6.2.Breakdown Data, by Key Manufacturer
    • 6.2.1.Established Players' Analysis
    • 6.2.2.Emerging Players' Analysis

7.Immunoassay For Neurological Biomarkers Market - By Disease Type

  • 7.1.Overview
    • 7.1.1.Segment Share Analysis, By Disease Type, 2023 & 2032 (%)
    • 7.1.2.Alzheimer's Disease
    • 7.1.3.Parkinson's Disease
    • 7.1.4.Huntington's Disease
    • 7.1.5.Amyotrophic Lateral Sclerosis (ALS)
    • 7.1.6.Spinal Muscular Atrophy (SMA)
    • 7.1.7.Others

8.Immunoassay For Neurological Biomarkers Market - By Product

  • 8.1.Overview
    • 8.1.1.Segment Share Analysis, By Product, 2023 & 2032 (%)
    • 8.1.2.Instruments
    • 8.1.3.Reagents
    • 8.1.4.Services

9.Immunoassay For Neurological Biomarkers Market - By End User

  • 9.1.Overview
    • 9.1.1.Segment Share Analysis, By End User, 2023 & 2032 (%)
    • 9.1.2.Hospitals
    • 9.1.3.Clinics
    • 9.1.4.Academic Organizations
    • 9.1.5.Biopharmaceutical Companies
    • 9.1.6.Pharmaceutical Companies
    • 9.1.7.Others

10.Immunoassay For Neurological Biomarkers Market - By Technology

  • 10.1.Overview
    • 10.1.1.Segment Share Analysis, By Technology, 2023 & 2032 (%)
    • 10.1.2.Radioimmunoassays (RIA)
    • 10.1.3.Polymerase Chain Reaction (PCR)
    • 10.1.4.ELISA
    • 10.1.5.Western Blot
    • 10.1.6.Rapid Tests
    • 10.1.7.ELISPOT

11.Immunoassay For Neurological Biomarkers Market- By Geography

  • 11.1.Introduction
    • 11.1.1.Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 11.2.North America
    • 11.2.1.Overview
    • 11.2.2.Immunoassay For Neurological Biomarkers Key Manufacturers in North America
    • 11.2.3.North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4.North America Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 11.2.5.North America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.2.6.North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.2.7.North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.2.8.U.S.
      • 11.2.8.1.Overview
      • 11.2.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3.U.S. Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.2.8.4.U.S. Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.2.8.5.U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.2.8.6.U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.2.9.Canada
      • 11.2.9.1.Overview
      • 11.2.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3.Canada Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.2.9.4.Canada Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.2.9.5.Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.2.9.6.Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 11.3.Europe
    • 11.3.1.Overview
    • 11.3.2.Immunoassay For Neurological Biomarkers Key Manufacturers in Europe
    • 11.3.3.Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4.Europe Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 11.3.5.Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.3.6.Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.7.Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.8.Germany
      • 11.3.8.1.Overview
      • 11.3.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3.Germany Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.3.8.4.Germany Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.8.5.Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.3.8.6.Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.9.Italy
      • 11.3.9.1.Overview
      • 11.3.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3.Italy Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.3.9.4.Italy Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.9.5.Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.3.9.6.Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.10.United Kingdom
      • 11.3.10.1.Overview
      • 11.3.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3.United Kingdom Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.3.10.4.United Kingdom Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.10.5.United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.3.10.6.United Kingdom Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.11.France
      • 11.3.11.1.Overview
      • 11.3.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3.France Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.3.11.4.France Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.11.5.France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.3.11.6.France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.12.Russia
      • 11.3.12.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.2.Russia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.3.12.3.Russia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.12.4.Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.3.12.5.Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.13.Netherlands
      • 11.3.13.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.2.Netherlands Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.3.13.3.Netherlands Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.13.4.Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.3.13.5.Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.14.Sweden
      • 11.3.14.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.2.Sweden Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.3.14.3.Sweden Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.14.4.Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.3.14.5.Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.15.Poland
      • 11.3.15.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.2.Poland Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.3.15.3.Poland Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.15.4.Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.3.15.5.Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.16.Rest of Europe
      • 11.3.16.1.Overview
      • 11.3.16.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3.Rest of the Europe Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.3.16.4.Rest of the Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.16.5.Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.3.16.6.Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 11.4.Asia Pacific (APAC)
    • 11.4.1.Overview
    • 11.4.2.Immunoassay For Neurological Biomarkers Key Manufacturers in Asia Pacific
    • 11.4.3.Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4.Asia Pacific Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 11.4.5.Asia Pacific Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.4.6.Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.7.Asia Pacific Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.8.India
      • 11.4.8.1.Overview
      • 11.4.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3.India Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.4.8.4.India Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.8.5.India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.4.8.6.India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.9.China
      • 11.4.9.1.Overview
      • 11.4.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3.China Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.4.9.4.China Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.9.5.China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.4.9.6.China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.10.Japan
      • 11.4.10.1.Overview
      • 11.4.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3.Japan Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.4.10.4.Japan Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.10.5.Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.4.10.6.Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.11.South Korea
      • 11.4.11.1.Overview
      • 11.4.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3.South Korea Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.4.11.4.South Korea Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.11.5.South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.4.11.6.South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.12.Australia
      • 11.4.12.1.Overview
      • 11.4.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3.Australia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.4.12.4.Australia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.12.5.Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.4.12.6.Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.13.Thailand
      • 11.4.13.1.Overview
      • 11.4.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3.Thailand Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.4.13.4.Thailand Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.13.5.Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.4.13.6.Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.14.Indonesia
      • 11.4.14.1.Overview
      • 11.4.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3.Indonesia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.4.14.4.Indonesia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.14.5.Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.4.14.6.Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.15.Philippines
      • 11.4.15.1.Overview
      • 11.4.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3.Philippines Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.4.15.4.Philippines Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.15.5.Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.4.15.6.Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.16.Rest of APAC
      • 11.4.16.1.Overview
      • 11.4.16.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3.Rest of APAC Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.4.16.4.Rest of APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.16.5.Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.4.16.6.Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 11.5.Latin America
    • 11.5.1.Overview
    • 11.5.2.Immunoassay For Neurological Biomarkers Key Manufacturers in Latin America
    • 11.5.3.Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4.Latin America Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 11.5.5.Latin America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.5.6.Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.7.Latin America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.5.8.Brazil
      • 11.5.8.1.Overview
      • 11.5.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3.Brazil Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.5.8.4.Brazil Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.5.8.5.Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.5.8.6.Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.5.9.Mexico
      • 11.5.9.1.Overview
      • 11.5.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3.Mexico Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.5.9.4.Mexico Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.5.9.5.Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.5.9.6.Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.5.10.Argentina
      • 11.5.10.1.Overview
      • 11.5.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3.Argentina Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.5.10.4.Argentina Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.5.10.5.Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.5.10.6.Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.5.11.Colombia
      • 11.5.11.1.Overview
      • 11.5.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3.Colombia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.5.11.4.Colombia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.5.11.5.Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.5.11.6.Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.5.12.Rest of LATAM
      • 11.5.12.1.Overview
      • 11.5.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3.Rest of LATAM Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.5.12.4.Rest of LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.5.12.5.Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.5.12.6.Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 11.6.Middle East and Africa
    • 11.6.1.Overview
    • 11.6.2.Immunoassay For Neurological Biomarkers Key Manufacturers in Middle East and Africa
    • 11.6.3.Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4.Middle East and Africa Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 11.6.5.Middle East and Africa Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.6.6.Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.7.Middle East and Africa Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.6.8.Saudi Arabia
      • 11.6.8.1.Overview
      • 11.6.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3.Saudi Arabia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.6.8.4.Saudi Arabia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.8.5.Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.6.8.6.Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.6.9.United Arab Emirates
      • 11.6.9.1.Overview
      • 11.6.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3.United Arab Emirates Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.6.9.4.United Arab Emirates Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.9.5.United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.6.9.6.United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.6.10.Israel
      • 11.6.10.1.Overview
      • 11.6.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3.Israel Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.6.10.4.Israel Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.10.5.Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.6.10.6.Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.6.11.Turkey
      • 11.6.11.1.Overview
      • 11.6.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3.Turkey Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.6.11.4.Turkey Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.11.5.Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.6.11.6.Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.6.12.Algeria
      • 11.6.12.1.Overview
      • 11.6.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3.Algeria Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.6.12.4.Algeria Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.12.5.Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.6.12.6.Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.6.13.Egypt
      • 11.6.13.1.Overview
      • 11.6.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3.Egypt Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.6.13.4.Egypt Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.13.5.Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.6.13.6.Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.6.14.Rest of MEA
      • 11.6.14.1.Overview
      • 11.6.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3.Rest of MEA Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.6.14.4.Rest of MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.14.5.Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.6.14.6.Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)

12.Key Vendor Analysis- Immunoassay For Neurological Biomarkers Industry

  • 12.1.Competitive Dashboard
  • 12.2.Company Profiles
    • 12.2.1.QIAGEN
    • 12.2.2.Abbott
    • 12.2.3.Merck & Co., Inc.
    • 12.2.4.Johnson & Johnson Services, Inc.
    • 12.2.5.Thermo Fisher Scientific, Inc.
    • 12.2.6.Bio-Rad Laboratories, Inc.
    • 12.2.7.Sysmex Corporation
    • 12.2.8.Merck KGaA
    • 12.2.9.F. Hoffmann La-Roche Ltd.
    • 12.2.10.Nimble Therapeutics
    • 12.2.11.ADx NeuroSciences NV
    • 12.2.12.Enrolmmun
    • 12.2.13.ACOBIOM
    • 12.2.14.Banyan Biomarkers Inc.
    • 12.2.15.Olink Biosciences
    • 12.2.16.Others

13.360 Degree Analyst View

14.Appendix

  • 14.1.Research Methodology
  • 14.2.References
  • 14.3.Abbreviations
  • 14.4.Disclaimer
  • 14.5.Contact Us